TP53 and neoplasm: In particular, when tumour formation was targeted to mammary luminal stem/progenitor cells (using the β-lactoglobulin promoter-driven CRE (BlgCre)), BlgCre Pten mice developed mainly AME and ASQC tumours, whereas BlgCre Pten p53 mice also developed MSCC and AC(NST) histotypes.